Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors

SIMPLE SUMMARY: No effective medical therapy exists for residual/recurrent nonfunctioning pituitary tumors (NFPTs). First-generation somatostatin analogs (SSAs) like octreotide targeting somatostatin receptor type 2 (SSTR2) are the mainstay therapy for functioning PTs, but have shown little effect i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulde, Sebastian, Wiedemann, Tobias, Schillmaier, Mathias, Valença, Isabel, Lupp, Amelie, Steiger, Katja, Yen, Hsi-Yu, Bäuerle, Stephen, Notni, Johannes, Luque, Raul, Schmid, Herbert, Schulz, Stefan, Ankerst, Donna P., Schilling, Franz, Pellegata, Natalia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235746/
https://www.ncbi.nlm.nih.gov/pubmed/34205778
http://dx.doi.org/10.3390/cancers13123097

Ejemplares similares

Ejemplares similares